UPDATE: SVB Leerink Upgrades Aclaris Therapeutis (ACRS) to Outperform; More than Doubles Price Target
Tweet Send to a Friend
(Updated - October 22, 2019 9:15 AM EDT)
(updated to add analyst comments)SVB Leerink analyst Pasha Sarraf upgraded Aclaris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst comments)SVB Leerink analyst Pasha Sarraf upgraded Aclaris ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
